Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Squamous Cell Carcinoma of Head”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04290546
What this trial is testing

CIML NK Cell in Head & Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckRecurrent Head and Neck Squamous Cell Carcinoma
Dana-Farber Cancer Institute 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06714266
What this trial is testing

Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Shandong Cancer Hospital and Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT06769113
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy

Who this might be right for
Esophageal Cancer
Shanghai Henlius Biotech 102
Testing effectiveness (Phase 2)Study completedNCT00448552
What this trial is testing

Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Miami 30
Large-scale testing (Phase 3)Study completedNCT07435324
What this trial is testing

A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
R-Pharm 161
Testing effectiveness (Phase 2)Study completedNCT00055770
What this trial is testing

Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+19 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT01016769
What this trial is testing

Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)

Who this might be right for
Squamous Cell CancerHead and Neck Cancer
Memorial Sloan Kettering Cancer Center 48
Testing effectiveness (Phase 2)WithdrawnNCT01427205
What this trial is testing

Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00093041
What this trial is testing

Zalutumumab in Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Genmab 28
Testing effectiveness (Phase 2)Ended earlyNCT00503776
What this trial is testing

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Who this might be right for
DysphagiaHead and Neck CancerMucositis+1 more
Vanderbilt-Ingram Cancer Center 41
Not applicableStudy completedNCT01619618
What this trial is testing

Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 183
Large-scale testing (Phase 3)Active Not RecruitingNCT05063552
What this trial is testing

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03049618
What this trial is testing

Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475

Who this might be right for
ALK Gene MutationBRAF Gene MutationEGFR Gene Mutation+9 more
University of Southern California 42
Large-scale testing (Phase 3)Study completedNCT00122460
What this trial is testing

Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)

Who this might be right for
Head and Neck Cancer
Merck KGaA, Darmstadt, Germany 442
Testing effectiveness (Phase 2)Study completedNCT00387335
What this trial is testing

Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Squamous Cell Carcinoma of the Hypopharynx+11 more
National Cancer Institute (NCI) 22
Not applicableStudy completedNCT00896896
What this trial is testing

Immunoreactivity to Cetuximab in Cancer Patients

Who this might be right for
Colorectal CancerHead and Neck Cancer
Vanderbilt-Ingram Cancer Center 538
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07628062
What this trial is testing

Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation

Who this might be right for
HPV-Positive Oropharyngeal Squamous Cell CarcinomaOropharyngeal Squamous Cell CarcinomaHead and Neck Cancer
ImmunityBio, Inc. 70
Not applicableLooking for participantsNCT06659146
What this trial is testing

Thermotherapy in Addition to SOC Palliative Radiotherapy

Who this might be right for
Head and Neck Squamous Cell CarcinomaCutaneous Squamous Cell CarcinomaBreast Cancer Recurrent
King's College London 60
Testing effectiveness (Phase 2)Study completedNCT01087970
What this trial is testing

Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Eli Lilly and Company 69
Testing effectiveness (Phase 2)Ended earlyNCT02633800
What this trial is testing

Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )

Who this might be right for
Head and Neck Neoplasms
Daiichi Sankyo 87
Next Page
430